Masaki, Tsutomu

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Llovet, J. M., Kudo, M., Merle, P., Meyer, T., Qin, S., Ikeda, M., Xu, R., Edeline, J., Ryoo, B.-Y., Ren, Z., et al. (2023) · The Lancet Oncology

Hepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Treatments and Studies

Cited by 469

Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy

Kitada, K., Nakano, D., Ohsaki, H., Hitomi, H., Minamino, T., Yatabe, J., Felder, R. A., Mori, H., Masaki, T., Kobori, H., et al. (2014) · Journal of Diabetes and its Complications

Chronic Kidney Disease and DiabetesTelomeres, Telomerase, and Senescence

Cited by 151

Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study

Nakai, S., Masaki, T., Kurokohchi, K., Deguchi, A., & Nishioka, M. (2000) · The American Journal of Gastroenterology

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 113

Aldosterone Induces Vascular Insulin Resistance by Increasing Insulin-Like Growth Factor-1 Receptor and Hybrid Receptor

Sherajee, S. J., Fujita, Y., Rafiq, K., Nakano, D., Mori, H., Masaki, T., Hara, T., Kohno, M., Nishiyama, A., & Hitomi, H. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology

Hormonal Regulation and HypertensionGrowth Hormone and Insulin-like Growth Factors

Cited by 73

Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control study

Matsumoto, K., Ohfuji, S., Abe, M., Komori, A., Takahashi, A., Fujii, H., Kawata, K., Noritake, H., Tadokoro, T., Honda, A., et al. (2022) · Journal of Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 35

A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis

Yagi, M., Matsumoto, K., Komori, A., Abe, M., Hashimoto, N., Inao, M., Namisaki, T., Kawata, K., Ninomiya, M., Fujii, H., et al. (2020) · Liver International

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 20